首页> 外文期刊>Bulletin of the Korean Chemical Society >Synthesis and Anticancer Activity of Some Novel 1,3-Diaryl/heteroarylprop-2-en-1-one Derivatives
【24h】

Synthesis and Anticancer Activity of Some Novel 1,3-Diaryl/heteroarylprop-2-en-1-one Derivatives

机译:某些新型1,3-二芳基/杂芳基丙-2-烯-1-酮衍生物的合成及抗癌活性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

In the present investigation, a series of some novel 1,3-diaryl/heteroarylprop-2-en-1-one derivatives (3a-j) have been synthesized and evaluated for their in vitro cytotoxicity against three cancer cell lines, two hepato-carcinoma cell lines HUH-7, Hep-3b and one leukemia cancer cell line MOLT-4. Based on these results, structure-activity relationship (SAR) was studied on modification of R~1 and R~2 to identify the compound with maximum potency. Amongst the compounds, 3b and 3d strongly inhibited the growth of Hep-3b and MOLT-4 cells with IC50 value of 3.39 and 3.63 uM respectively. The results obtained from the inhibitory study had further been supported by the reactive oxygen species (ROS) measurement using flow cytometry in MOLT-4 cells. These observations collectively reveal that compounds comprising 1,3-diarylprop-2-en-1-one framework with pyrazole ring at position-3 and heteroaryl/aryl substituents at position-1 can be used as promising anticancer agents.
机译:在本研究中,已合成了一系列一些新颖的1,3-二芳基/杂芳基丙-2-烯-1-酮衍生物(3a-j),并评估了它们对三种癌细胞系,两种肝癌细胞系的体外细胞毒性。癌细胞系HUH-7,Hep-3b和一种白血病癌细胞系MOLT-4。基于这些结果,研究了结构活性关系(SAR)对R〜1和R〜2的修饰,以鉴定具有最大效价的化合物。在这些化合物中,3b和3d强烈抑制Hep-3b和MOLT-4细胞的生长,IC50值分别为3.39和3.63 uM。从抑制研究获得的结果进一步得到了使用流式细胞术在MOLT-4细胞中进行活性氧(ROS)测量的支持。这些观察结果共同表明,包含具有在3位上的吡唑环和在1位上的杂芳基/芳基取代基的1,3-二芳基丙-2-烯-1-酮骨架的化合物可以用作有希望的抗癌剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号